What is the price-to-earnings ratio of Vitrolife?
The price-earnings ratio of Vitrolife is currently 40.02.
Vitrolife P/E 2024
Vitrolife P/E
40.02
Ticker
VITR.ST
ISIN
SE0011205202
WKN
A2JLT3
As of Sep 28, 2024, Vitrolife's P/E ratio was 40.02, a -617.05% change from the -7.74 P/E ratio recorded in the previous year.
The Vitrolife P/E history
Vitrolife Aktienanalyse
What does Vitrolife do?
Vitrolife AB is a Swedish biotech company specializing in the development and marketing of products for in vitro fertilization (IVF) and regenerative medicine. It was founded in 1994 and has over 390 employees worldwide. The company's main business is IVF, offering a wide range of essential products for IVF treatment such as culture media, devices for semen analysis and preparation, embryo transfer techniques, and products for biopsy examinations and cryopreservation. Vitrolife has a presence in 110 countries and has expanded its market to China where there is a high demand for fertility treatments. The company also offers medical equipment for regenerative treatments. Vitrolife is a leading player in the IVF industry known for its high product quality and innovation. It collaborates with universities and research institutions globally to improve IVF technology and success rates. The company places importance on sustainability and environmental protection, using 100% animal-free ingredients in their culture media and practicing recycling and waste reduction in their production facilities. In summary, Vitrolife offers a wide range of products for IVF and regenerative medicine, with a focus on supporting IVF treatments. The company is a leader in its industry and actively participates in research. It is committed to sustainability and environmental responsibility. Vitrolife ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/E Details
Deciphering Vitrolife's P/E Ratio
The Price to Earnings (P/E) Ratio of Vitrolife is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.
Year-to-Year Comparison
Assessing Vitrolife's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.
Impact on Investments
The P/E ratio of Vitrolife is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.
Interpreting P/E Ratio Fluctuations
Fluctuations in Vitrolife’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.
Frequently Asked Questions about Vitrolife stock
How has the price-earnings ratio of Vitrolife changed compared to last year?
The price-to-earnings ratio of Vitrolife has increased by -617.05% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Vitrolife high compared to other companies?
Yes, the price-to-earnings ratio of Vitrolife is high compared to other companies.
How does an increase in the price-earnings ratio of Vitrolife affect the company?
An increase in the price-earnings ratio of Vitrolife would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Vitrolife affect the company?
A decrease in the price-earnings ratio of Vitrolife would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Vitrolife?
Some factors that influence the price-earnings ratio of Vitrolife are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Vitrolife pay?
Over the past 12 months, Vitrolife paid a dividend of 0.85 SEK . This corresponds to a dividend yield of about 0.33 %. For the coming 12 months, Vitrolife is expected to pay a dividend of 0.86 SEK.
What is the dividend yield of Vitrolife?
The current dividend yield of Vitrolife is 0.33 %.
When does Vitrolife pay dividends?
Vitrolife pays a quarterly dividend. This is distributed in the months of May, May, May, June.
How secure is the dividend of Vitrolife?
Vitrolife paid dividends every year for the past 6 years.
What is the dividend of Vitrolife?
For the upcoming 12 months, dividends amounting to 0.86 SEK are expected. This corresponds to a dividend yield of 0.34 %.
In which sector is Vitrolife located?
Vitrolife is assigned to the 'Health' sector.
Wann musste ich die Aktien von Vitrolife kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Vitrolife from 5/14/2024 amounting to 1 SEK, you needed to have the stock in your portfolio before the ex-date on 5/7/2024.
When did Vitrolife pay the last dividend?
The last dividend was paid out on 5/14/2024.
What was the dividend of Vitrolife in the year 2023?
In the year 2023, Vitrolife distributed 0.8 SEK as dividends.
In which currency does Vitrolife pay out the dividend?
The dividends of Vitrolife are distributed in SEK.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Vitrolife
Our stock analysis for Vitrolife Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vitrolife Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
